IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q4 2014 Holdings

Filed 2015-02-13 | 19 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$40.3M3,608,17198.5%
Esperion Therapeutics Inc(ESPR)COM29664W105$83.1K2,054,5940.2%
Cempra IncCOM15130J109$77.4K3,293,0600.2%
Zeltiq Aesthetics IncCOM98933Q108$72.5K2,597,7420.2%
Chimerix Inc(CMRXEUR)COM16934W106$61.3K1,522,9430.1%
Catalent Inc(CTLTEUR)COM148806102$49.1K1,761,2250.1%
T2 Biosystems IncCOM89853L104$48.5K2,523,3000.1%
Versartis IncCOM92529L102$44.8K1,994,5680.1%
Loxo Oncology IncCOM548862101$40.6K3,452,4930.1%
Paratek Pharmaceuticals, Inc.COM699374302$26.3K682,6800.1%
TransEnterix IncCOM NEW89366M201$24.3K8,335,8190.1%
Dermira Inc.(DERMEUR)COM24983L104$20.0K1,102,0460.0%
Pernix Therapeutics Hldgs inCOM71426V108$18.9K2,010,0000.0%
Sorrento Therapeutics Inc(SRNE)COM NEW83587F202$17.8K1,763,5000.0%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$13.3K2,171,8310.0%
Intersect ENT IncCOM46071F103$6.5K350,0000.0%
Lombard MED IncCOMG55598109$5.8K886,3630.0%
Roka Bioscience IncCOM775431109$5.0K1,122,4170.0%
MEI Pharma IncCOM NEW55279B202$4.3K1,011,8000.0%